Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
31,497,581
-
Shares change
-
+3,149,039
-
Total reported value, excl. options
-
$2,907,518,951
-
Value change
-
+$295,483,780
-
Put/Call ratio
-
130%
-
Number of buys
-
139
-
Number of sells
-
-110
-
Price
-
$92.31
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q2 2025
305 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q2 2025.
GeneDx Holdings Corp. - Common Stock (WGS) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,497,581 shares
.
Largest 10 shareholders include Casdin Capital, LLC (3,507,164 shares), Corvex Management LP (3,058,629 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,631,402 shares), BlackRock, Inc. (1,434,634 shares), Pentwater Capital Management LP (1,220,000 shares), VANGUARD GROUP INC (1,180,923 shares), GOLDMAN SACHS GROUP INC (1,049,441 shares), T. Rowe Price Investment Management, Inc. (1,037,116 shares), UBS Group AG (1,001,720 shares), and ORACLE INVESTMENT MANAGEMENT INC (922,454 shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.